Tandem Meetings 2026

At this year’s Tandem Meetings, taking place 4–7 February 2026, in Salt Lake City, Utah, we are proud to be sharing new data and engaging with the scientific community to drive progress in the care of people living with blood cancers.

You can see the conference program here:

Conference Program

We are pleased to share new research to be presented at this year's Tandem Meetings.

Abstract ID

Title / Presenting Author

Room / Date

74

A Phase 1 Study of KITE-753 or KITE-363 in Patients With Relapsed/Refractory B-Cell Lymphoma: Initial Safety and Preliminary Efficacy of KITE-753 and Updated Results of KITE-363

Presenting Author: Saurabh Dahiya

Room: Ballroom AB (Salt Palace Convention Center)

Date: Saturday, Feb 7, 10:45 AM - 11:00 AM MST

Abstract ID

Title / Presenting Author

Room / Date

237

Inpatient Versus Outpatient Administration of CAR T-cell Therapy in relapsed/refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL): Real-World 30- and 60-Day Costs and Resource Utilization

Presenting Author: Samuel Hong

Room: Poster Hall AB (Salt Palace Convention Center)

Date: Thurs, Feb 5, 2026, 6:30 PM MST

513

Estimating the survival impact of not receiving CAR T-cell (CAR T) therapy when eligible in patients with Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) in the United States (US)

Presenting Author: Frederick Locke

Room: Poster Hall AB (Salt Palace Convention Center)

Date: Thurs, Feb 5, 2026, 6:30 PM MST

269

Systematic Literature Review of Characteristics Associated with Safety and Healthcare Resource Utilization Outcomes in Various Settings of Care for Chimeric Antigen Receptor T-Cell Therapy

Presenting Author: Samuel Hong

Room: Poster Hall AB (Salt Palace Convention Center)

Date: Thurs, Feb 5, 2026, 6:30 PM MST

398
Collaboration

Visualizing Geographic Variation and Systemic Inequities of Disease Burden and CAR T-Cell Therapy Access in Multiple Myeloma in the US

Presenting Author: Brandon Blue

Room: Poster Hall AB (Salt Palace Convention Center)

Date: Thurs, Feb 5, 2026, 6:30 PM MST

279
Collaboration

Anito-Cel's D-Domain Binder Has a Fast Off-Rate and Contributes to Its Differentiated Pharmacology Profile in Multiple Myeloma

Presenting Author: Kevin Hart

Room: Poster Hall AB (Salt Palace Convention Center)

Date: Thurs, Feb 5, 2026, 6:30 PM MST

232
Collaboration

Impact of treatment and sequencing with CAR T-cell therapies and bispecific antibodies on long-term survival in 4L+ RRMM in the US: a simulation model

Presenting Author: Jodi Lipof 

Room: Poster Hall AB (Salt Palace Convention Center)

Date: Thurs, Feb 5, 2026, 6:30 PM MST

Are you a healthcare professional?

Learn more about Kite’s presence at the 2026 Tandem Meetings

Find out more